Last edition
News about "IMDELLTRA"
US FDA Approves Reduced Monitoring Time for First 2 Doses of Imdelltra
The US Food and Drug Administration (FDA) has approved reduced monitoring time for the first 2 doses of Imdelltra, supporting broader community access for patients with extensive-stage Small Cell Lung Cancer (SCLC).
Imdelltra | 15/09/2026 | By News Bureau
Amgen Reports Positive Interim Results for IMDELLTRA in Small Cell Lung Cancer Study
IMDELLTRA demonstrated statistically significant and clinically meaningful improvement in overall survival compared to local standard-of-care chemotherapy.
IMDELLTRA | 14/04/2025 | By Abha | 616
FDA Approves Amgen's IMDELLTRA for Advanced Small Cell Lung Cancer
The approval is based on the encouraging response rate and duration of response (DoR) observed in clinical studies, under the FDA's accelerated approval pathway.
IMDELLTRA | 17/05/2024 | By Abha | 952
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy